Medicine & Life Sciences
Hemagglutinins
100%
Vaccines
70%
Influenza Vaccines
69%
Newcastle disease virus
67%
Coronavirus
62%
Severe Acute Respiratory Syndrome
57%
Orthomyxoviridae
44%
Influenza B virus
36%
Vaccination
32%
Antibodies
27%
Human Influenza
24%
Inactivated Vaccines
23%
Antibody Formation
20%
Viruses
19%
Neutralizing Antibodies
18%
SARS Virus
18%
Safety
18%
Disease Vectors
16%
Pandemics
15%
Immunity
15%
Hemagglutination
15%
Placebos
15%
Neuraminidase
13%
Ovum
12%
Coronavirus Spike Glycoproteins
12%
Proteins
11%
1018 oligonucleotide
10%
Mucosal Immunity
10%
Epitopes
10%
Broadly Neutralizing Antibodies
9%
Vietnam
9%
H3N2 Subtype Influenza A Virus
9%
Influenza A virus
9%
Immunization
8%
Head
8%
Ferrets
8%
RNA
7%
Clinical Trials, Phase I
7%
Mexico
7%
Humoral Immunity
7%
Intranasal Administration
6%
Thailand
6%
Product Packaging
6%
Messenger RNA
6%
Mutagenesis
5%
Cellular Immunity
5%
Cross Protection
5%
Polysaccharides
5%
Agriculture & Biology
hemagglutinins
37%
Influenza B virus
35%
Severe acute respiratory syndrome coronavirus
28%
Orthomyxoviridae
22%
immunogenicity
21%
vaccines
19%
vaccination
14%
Avian orthoavulavirus 1
13%
sialidase
12%
mice
12%
animal models
11%
RNA packaging
9%
Coronavirinae
8%
antibody formation
8%
Influenza A virus
7%
influenza vaccines
7%
ferrets
7%
antibodies
6%
influenza
6%
hemagglutination
6%
placebos
6%
antigenic variation
5%
Vietnam
5%
viruses
5%
neutralizing antibodies
5%
immunity
5%
mutagenesis
5%
transposons
5%